Investigating a small peptide for neurological diseases
Official title: NON-GLP DOSE-RANGE FINDING AND GLP TOXICITY STUDIES AND IN VITRO DRUG-DRUG INTERACTION STUDIES FOR A SMALL PEPTIDE
Funded at Battelle Centers/pub Hlth Res & Evaluatn · NIH-11212437 · Data updated 2026-11-12
This study is working on creating new treatments for neurological diseases by helping researchers test a small peptide, which could lead to better options for patients like you in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Battelle Centers/pub Hlth Res & Evaluatn NIH-funded |
| Lab location | 1 site (Columbus, United States) |
| Project start | March 26, 2024 |
| Project end | March 25, 2027 |
| Funding year | 2024 |
| Award (this year) | $1,924,589 |
| NIH project number | 75N95022D00021-0-759502400002-1 |
| Project ID | NIH-11212437 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research are individuals with neurological disorders who may be eligible for new biological therapies.
✕Less likely to help
Patients with non-neurological conditions or those who do not meet the eligibility criteria for the new therapies may not receive any benefit from this research.
What this research studies
This research focuses on developing biological therapeutics for neurological diseases by providing essential drug-development services to innovators in the field. It includes conducting dose-range finding, toxicity studies, and in vitro drug-drug interaction studies for a small peptide. The approach aims to support the advancement of candidate products to phase I clinical trials by offering expertise in assay development, pharmacokinetics, and toxicological studies. Patients may benefit from the development of new treatments that target neurological disorders.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic options for patients suffering from neurological diseases.
How similar studies have gone: Other research in the field of biological therapeutics for neurological diseases has shown promise, indicating that this approach could be effective.
Where this research is happening
-
Battelle Centers/pub Hlth Res & Evaluatn
Columbus, United States Active
Researchers
- Principal investigator: Pang, Kaitlin — Battelle Centers/pub Hlth Res & Evaluatn
- Study coordinator: Pang, Kaitlin
Related research
Other NIH-funded projects on the same topics.
-
Testing the safety of vaccines and biologics for infectious diseases
This study is looking at new vaccines to help protect people from infectious diseases, including those that could come from bioterrorism, and aims to make these vaccines safer and more effective for everyone.
-
Developing antibody treatments for Duchenne's muscular dystrophy
This study is working on a new treatment for Duchenne's muscular dystrophy (DMD) using a special antibody, which could help improve the lives of patients by targeting the root causes of the condition.
-
Monitoring heart and blood pressure changes in animals exposed to toxic chemicals
This study is looking at how tracking heart rate and blood pressure in animals can help us spot early signs of harm from toxic chemicals, which could lead to better ways to monitor and protect people from similar dangers.
-
Creating a system to test inhalation exposure to air pollutants in the lab
This study is working on a new lab system that safely tests how different air pollutants and toxic substances affect breathing, which could help us understand their impact on people and animals without using live tests.
-
Evaluating the effects of certain flame retardants on rats during development.
This study is looking at how certain chemicals, found in some products, might affect the health and development of baby rats when their mothers are pregnant or nursing, to help keep people safe from harmful substances.
-
Evaluating the health risks of naturally occurring asbestos and related mineral fibers.
This study is looking at how breathing in natural asbestos and similar fibers might harm health, especially the lungs, using tests on lab rats, to help keep people safe from these potential dangers.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.